However, recent studies have shown that FAK PROTAC addition to tumor cells in vitro at sub-micromolar concentrations recapitulates many of the FAK inhibitor-associated cell phenotypes (Hou et al., 2023; Law et al., 2021). Here, PTK2 is linked to neoplasm.